KRAS and cardiofaciocutaneous syndrome: Constitutive active mutations in more downstream genes such as KRAS and BRAF result in an increased activation of the MAPK/ERK pathway and hence in short stature syndromes as for example Noonan or cardio-facio-cutaneous syndrome [25], [34].